Pursue Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Pursue Wealth Partners's LLY Position: Q3 2026 in Review
Pursue Wealth Partners reduced its Eli Lilly (LLY) stake by 16% in Q3 2026, selling an estimated $240K and leaving 1,101 shares worth $1.27M. The position accounts for 0.68% of the portfolio, ranked #38.
Pursue Wealth Partners first reported a position in LLY in Q1 2022 and has held it in 7 quarters since. The position peaked at $2.3M in Q4 2025. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Pursue Wealth Partners held 1,101 shares of Eli Lilly worth $1.27M as of Q3 2026.
- Pursue Wealth Partners sold 203 Eli Lilly shares in Q3 2026, an estimated $240K.
- Eli Lilly made up 0.68% of Pursue Wealth Partners's portfolio in Q3 2026, its #38 holding.
- Pursue Wealth Partners first reported a position in Eli Lilly in Q1 2022 and has held it in 7 quarters since.
- Pursue Wealth Partners's Eli Lilly position peaked at $2.3M in Q4 2025.
- 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Pursue Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.